Herve J Brisse
Overview
Explore the profile of Herve J Brisse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klijanienko J, Gauthier A, Brisse H, Pierron G, Orbach D
Diagn Cytopathol
. 2025 Mar;
53(4):E61-E65.
PMID: 40026174
Keratocystoma is a rare benign salivary gland tumor described in 1999. Only 14 cases have been reported in the histopathological literature, with three of them having had a preoperative fine...
2.
Malhaire C, Umay O, Cockenpot V, Selhane F, Ramtohul T, Reyal F, et al.
Eur Radiol
. 2025 Feb;
PMID: 39920303
Objectives: To predict axillary node residual disease in women treated for node-positive breast cancer (BC) by neoadjuvant therapy (NAT), using breast BI-RADS MRI features and axillary ultrasound at baseline. Material...
3.
Brisse H, Cyrta J, Nicolas N, Cardoen L, El Zein S, Thibault L, et al.
Can J Ophthalmol
. 2024 Nov;
PMID: 39542032
Objective: To assess the feasibility, accuracy, and safety of ultrasound (US)-guided coaxial core-needle biopsy (CNB) for histomolecular diagnosis of extra-ocular orbital soft tissue tumours as a minimally invasive alternative to...
4.
de Bloeme C, Jansen R, Cardoen L, Goricke S, van Elst S, Jessen J, et al.
Sci Rep
. 2024 Oct;
14(1):25103.
PMID: 39443629
MYCN-amplified RB1 wild-type (MYCNRB1) retinoblastoma is a rare and aggressive subtype, often resistant to standard therapies. Identifying unique MRI features is crucial for diagnosing this subtype, as biopsy is not...
5.
Ramtohul T, Lepagney V, Bonneau C, Jin M, Menet E, Sauge J, et al.
Radiology
. 2024 Sep;
312(3):e240575.
PMID: 39225608
Background Neoadjuvant chemoimmunotherapy (NACI) has significantly increased the rate of pathologic complete response (pCR) in patients with early-stage triple-negative breast cancer (TNBC), although predictors of response to this regimen have...
6.
Gajdzis P, Brisse H, Klijanienko J
Cancer Cytopathol
. 2024 Aug;
132(12):768-778.
PMID: 39212584
Background: Recently, a new World Health Organization Reporting System for Soft Tissue Cytopathology (WHO System) was introduced. To analyze the value of this system, routine fine-needle aspiration soft tissue tumor...
7.
Espinoza A, Bagatell R, McHugh K, Naranjo A, Van Ryn C, Rojas Y, et al.
Pediatr Blood Cancer
. 2024 Jul;
71(10):e31218.
PMID: 39072986
Background: Image-defined risk factors (IDRFs) were promulgated for predicting the feasibility and safety of complete primary tumor resection in children with neuroblastoma (NB). There is limited understanding of the impact...
8.
de Bloeme C, van Elst S, Galluzzi P, Jansen R, de Haan J, Goricke S, et al.
Cancers (Basel)
. 2024 May;
16(10).
PMID: 38791976
This retrospective multicenter study examines therapy-induced orbital and ocular MRI findings in retinoblastoma patients following selective intra-arterial chemotherapy (SIAC) and quantifies the impact of SIAC on ocular and optic nerve...
9.
Hermann A, Lemelle L, Pierron G, Gauthier A, Nicolas N, Cardoen L, et al.
Br J Radiol
. 2024 Feb;
97(1156):734-743.
PMID: 38327010
Objectives: The neurotrophic tyrosine receptor kinase (NTRK) fusion transcript (FT) is a major genetic landmark of infantile fibrosarcoma (IFS) and cellular congenital mesoblastic nephroma (cCMN) but is also described in...
10.
de Bloeme C, Jansen R, Goricke S, Grauwels S, van Elst S, Ketteler P, et al.
Eur Radiol
. 2023 Dec;
34(7):4638-4648.
PMID: 38087063
Objectives: To assess the diagnostic accuracy of nerve thickening on MRI to predict early-stage postlaminar optic nerve invasion (PLONI) in retinoblastoma. Furthermore, this study aimed to incorporate measurements into a...